Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products Reimbursement

Dáil Éireann Debate, Thursday - 24 November 2016

Thursday, 24 November 2016

Ceisteanna (177, 180)

Richard Boyd Barrett

Ceist:

177. Deputy Richard Boyd Barrett asked the Minister for Health if his attention has been drawn to the fact that prescribed low protein foods are required to prevent neurological damage and to supplement the diet of adults and children with phenylketonuria, PKU; if his attention has further been drawn to the fact that no new low protein products have been added to the long-term illness card list in more than six years; if he will ensure a full and appropriate updated list of foods prescribed for PKU is added to the reimbursement list; and if he will make a statement on the matter. [36609/16]

Amharc ar fhreagra

Gino Kenny

Ceist:

180. Deputy Gino Kenny asked the Minister for Health if his attention has been drawn to the fact that prescribed low protein foods are required to prevent neurological damage and to supplement the diet of adults and children with phenylketonuria, PKU; if his attention has further been drawn to the fact that no new low protein products have been added to the long-term illness card list in more than six years; if he will ensure a full and appropriate updated list of foods prescribed for PKU is added to the reimbursement list; and if he will make a statement on the matter. [36618/16]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 177 and 180 together.

The HSE has statutory responsibility for decisions on pricing and reimbursement of products under the community drug schemes, including the LTI Scheme, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Barr
Roinn